Mankind Pharma consolidated net profit declines 21.72% in the September 2025 quarter
Sales rise 20.77% to Rs 3697.16 crore
Net profit of Mankind Pharma declined 21.72% to Rs 511.51 crore in the quarter ended September 2025 as against Rs 653.47 crore during the previous quarter ended September 2024. Sales rose 20.77% to Rs 3697.16 crore in the quarter ended September 2025 as against Rs 3061.43 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales3697.163061.43 21 OPM %24.9227.67 -PBDT845.84951.72 -11 PBT624.02851.23 -27 NP511.51653.47 -22Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 06 2025 | 6:13 PM IST